BSEGian Life Care Ltd· Healthcare ServicesHighNeutral
Announced Tue, 2 Sept, 2025 · 20:39 IST

Results for the Quarter ended June 30, 2025

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.4%Reaction day
₹14.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+0.4% vs market
Healthcare Service Provider peers, median of 23sector+0.9%+0.5% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.4+1.0+0.4+0.9+0.5
Next day
+2.1+0.3+1.8+0.9+1.2
2d
+4.6+0.3+4.3+0.8+3.9
3d
+7.0+0.8+6.2+0.1+6.9
4d
+8.2+0.9+7.3-1.5+9.7
5d
+12.1+1.4+10.8+1.8+10.3
1w
+19.6+1.2+18.5+0.5+19.1
15d
+14.1+1.8+12.3-0.0+14.2
1m
+8.9+0.1+8.8-3.2+12.2
2m
-12.9+2.4-15.2-0.6-12.2
3m
-24.3-2.8-21.5-11.9-12.3
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gian Life Care Ltd has submitted its standalone financial results for the first quarter of FY2025-26 (quarter ended June 30, 2025) to BSE. The detailed figures covering revenue, expenses, operating profit (EBITDA), and profit after tax (PAT) were not included in the text provided for analysis, so specific numbers cannot be reported here. This is a routine quarterly compliance filing under SEBI's listing obligations. Shareholders should refer to the full results PDF on the BSE corporate announcements page for the exact financial performance, year-on-year comparisons, and segment-wise breakdown.

Likely market impact

Without access to the detailed numbers, no specific directional impact on the stock or shareholders can be assessed. Investors should review the full results document and compare them with prior quarters and broker estimates before drawing conclusions.